|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Additional narrative: complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Device report from synthes reports an event in australia as follows: it was reported that during a procedure on (b)(6) 2023, the surgeon was performing an l4/5 and l5/s1 instrumented fusion with interbody fusions.The surgeon inserted a non-synthes needle followed by a synthes guidewire.It was noted on imaging that a piece of the guidewire had broken off into the vertebral body.The broken material remained in-situ and all implants were successfully implanted and the procedure completed.There was no delay to surgery.This report involves one viper system nitinol guidewire, blunt and disposable 1.45mm.This is report 1 of 1 for (b)(4).
|